Phillips-Medisize Finalizes Deal to Expand Manufacturing Presence With Its Largest Facility in Wisconsin
HUDSON, WI – October 26, 2018 – Phillips-Medisize, a Molex company, closed on its purchase of 34 undeveloped acres in the city of Hudson, Wisconsin, to expand its high-tech and FDA-regulated manufacturing operations. Construction of the 180,000-sq. ft. building at the St. Croix Meadows site is expected to commence later in 2018 for completion by mid-2020, making it Phillips-Medisize’s single largest manufacturing facility in west central Wisconsin and supporting at least 200 jobs for skilled manufacturing and engineering employees.
It will follow cGMP-compliant, FDA-approved facility guidelines and clean room practices, as well as incorporate state-of-the-art equipment to meet the requisite quality production standards. The anticipated investment in the new facility will exceed $40 million, underscoring the company’s commitment to better serve its customers and the community.
Phillips-Medisize CEO and President Matt Jennings stated, “Our company was founded in Wisconsin, and we are proud to further expand our five decades of Wisconsin operations into St. Croix Meadows. This strengthens our ability to be an end-to-end provider of innovation, development and manufacturing solutions to the pharmaceutical, diagnostics and medical device industries.”
Phillips-Medisize, LLC, a Molex company, is an end-to-end provider of innovation, development and manufacturing solutions to the pharmaceutical, diagnostics, and medical device market segments. Backed by the combined global resources of Molex and its parent company Koch Industries, Phillips-Medisize’s core advantage is the knowledge of its people to integrate design, molding, electronics, and automation, providing innovative, high-quality manufacturing solutions.
For more information, contact:
Phone +1 firstname.lastname@example.org